Cargando…
A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation
Biologic agents have revolutionized the management of serious health conditions in the last two decades. The use of “targeted therapy” brings not only better progression free survivals and overall survivals, but also better toxicity profiles and quality of life benefits, compared to empirical pallia...
Autores principales: | García, Jorge J., Raez, Luis E., Rosas, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653109/ https://www.ncbi.nlm.nih.gov/pubmed/33209630 http://dx.doi.org/10.21037/tlcr-20-601 |
Ejemplares similares
-
The biosimilars journey: current status and ongoing challenges
por: Kos, Igor Age, et al.
Publicado: (2018) -
Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab
por: Kolberg, Hans-Christian, et al.
Publicado: (2019) -
Journey of a therapeutic poison: Botulinum toxin A and its biosimilars
por: Bhattacharjee, Kasturi, et al.
Publicado: (2021) -
Scientific Evidence of Health Benefits by Practicing Mantra Meditation: Narrative Review
por: Tseng, Ampere A.
Publicado: (2022) -
Biosimilar and interchangeable: Inseparable scientific concepts?
por: de Mora, Fernando, et al.
Publicado: (2019)